Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « Qin Li »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Qijun Chen < Qin Li < Qing-Peng Kong  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000015 (2016-07-13) Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Yang Jianzhong [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [Royaume-Uni]An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000016 (2016-02) Mathieu Bourdenx [France] ; Sandra Dovero [France] ; Philippe De Deurwaerdère [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [Royaume-Uni]Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey
000017 (2016-01-21) Thibaud Thiollier [France] ; Caisheng Wu [République populaire de Chine] ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang [République populaire de Chine] ; Erwan Bezard [France]Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson disease.
000033 (2016) Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France]Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
000050 (2016) Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie]Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000051 (2016) Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Jianzhong Yang [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [France]An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000078 (2015) Mathieu Bourdenx [France] ; Sandra Dovero [France] ; Michel Engeln [France] ; Simone Bido [France] ; Matthieu F. Bastide [France] ; Nathalie Dutheil [France] ; Isabel Vollenweider [Suisse] ; Laetitia Baud [Suisse] ; Camille Piron [France] ; Virginie Grouthier [France] ; Thomas Boraud [France] ; Grégory Porras [Royaume-Uni] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Veerle Baekelandt [Belgique] ; Dieter Scheller [Belgique] ; Anne Michel [Belgique] ; Pierre-Olivier Fernagut [France] ; François Georges [France] ; Grégoire Courtine [Suisse] ; Erwan Bezard [France] ; Benjamin Dehay [France]Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
000103 (2014-07) Erwan Bezard [France] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Françoise Girard [France] ; Vincent Mutel [Suisse] ; Charlotte Keywood [Suisse] ; Francois Tison [France] ; Olivier Rascol [France] ; Sonia M. Poli [Italie]The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model
000104 (2014-04-30) Wai Kin D. Ko [Royaume-Uni] ; Qin Li [République populaire de Chine] ; Erwan Bezard [France]Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease.
000124 (2014) Gregory Porras [France, Royaume-Uni] ; Philippe De Deurwaerdere [France] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Matteo Marti [Italie] ; Rudolf Morgenstern [Allemagne] ; Reinhard Sohr [Allemagne] ; Erwan Bezard [France, Royaume-Uni, République populaire de Chine] ; Michele Morari [Italie] ; Wassilios G. Meissner [France]L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
000135 (2014) Mathieu Bourdenx [France] ; Anna Nilsson [Suède] ; Henrik Wadensten [Suède] ; Maria F Lth [Suède] ; Qin Li [République populaire de Chine] ; Alan R. Crossman [Royaume-Uni] ; Per E. Andrén [Suède] ; Erwan Bezard [République populaire de Chine]Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia.
000174 (2013) Erwan Bezard [France, République populaire de Chine] ; Elisabetta Tronci [Italie, Suède] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [République populaire de Chine, Royaume-Uni] ; Gregory Porras [Royaume-Uni] ; Anders Björklund [Suède] ; Manolo Carta [Italie, Suède]Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia
000183 (2013) Jay S. Schneider [États-Unis] ; Elsa Y. Pioli [République populaire de Chine, Royaume-Uni] ; Yang Jianzhong [République populaire de Chine, Royaume-Uni] ; Qin Li [République populaire de Chine, Royaume-Uni] ; Erwan Bezard [République populaire de Chine, Royaume-Uni, France]Levodopa improves motor deficits but can further disrupt cognition in a macaque parkinson model
000313 (2010) Pierre-Olivier Fernagut [France] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Sandra Dovero [France] ; Piu Chan [République populaire de Chine] ; Tao Wu [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Zhenwen Chen [République populaire de Chine] ; Erwan Bezard [France, République populaire de Chine]Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
000399 (2008) Birger Scholz [Suède] ; Marcus Svensson [Suède] ; Henrik Alm [Suède] ; Karl Sköld [Suède] ; Maria F Lth [Suède] ; Kim Kultima [Suède] ; Céline Guigoni [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Alan R. Crossman [Royaume-Uni] ; Erwan Bezard [France] ; Per E. Andrén [Suède]Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure

List of associated KwdEn.i

Nombre de
documents		Descripteur
6Animals
5Female
4Disease Models, Animal
3Levodopa (adverse effects)
3Levodopa (pharmacology)
3Macaca mulatta
3Male
3Parkinson Disease (drug therapy)
2Antiparkinson Agents (administration & dosage)
2Antiparkinson Agents (pharmacology)
2Corpus Striatum (drug effects)
2Corpus Striatum (metabolism)
2Dopamine (metabolism)
2Dopamine Agents (adverse effects)
2Dyskinesia, Drug-Induced (drug therapy)
2Levodopa (administration & dosage)
2Macaca fascicularis
2Rats
2Rats, Sprague-Dawley
11-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
11-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)
11-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)
1Amantadine (therapeutic use)
1Amphetamine
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (toxicity)
1Apomorphine (pharmacology)
1Autoradiography
1Behavior, Animal (drug effects)
1Benserazide (adverse effects)
1Benserazide (pharmacokinetics)
1Blood-Brain Barrier (drug effects)
1Brain (drug effects)
1Corpus Striatum (pathology)
1Dopamine Agents (pharmacokinetics)
1Dopamine Plasma Membrane Transport Proteins (metabolism)
1Drug Combinations
1Drug Therapy, Combination
1Dyskinesia, Drug-Induced (etiology)
1Dyskinesia, Drug-Induced (metabolism)
1Dyskinesia, Drug-Induced (prevention & control)
1Dyskinesias (etiology)
1Dyskinesias (metabolism)
1Enkephalins (analysis)
1Enkephalins (metabolism)
1Globus Pallidus (chemistry)
1Globus Pallidus (metabolism)
1Levodopa (pharmacokinetics)
1Levodopa (toxicity)
1Macaca
1Medial Forebrain Bundle (physiology)
1Motor Activity (drug effects)
1Neuropeptides (analysis)
1Neuropeptides (metabolism)
1Oxidopamine (toxicity)
1Parkinson Disease (etiology)
1Parkinson Disease (metabolism)
1Parkinson Disease, Secondary (chemically induced)
1Parkinson Disease, Secondary (etiology)
1Parkinson Disease, Secondary (metabolism)
1Parkinson Disease, Secondary (prevention & control)
1Parkinsonian Disorders (drug therapy)
1Parkinsonian Disorders (metabolism)
1Permeability (drug effects)
1Piperazines (administration & dosage)
1Piperazines (pharmacology)
1Piperazines (therapeutic use)
1Protein Binding (drug effects)
1Protein Precursors (analysis)
1Protein Precursors (metabolism)
1Psychomotor Performance (drug effects)
1Putamen (chemistry)
1Putamen (metabolism)
1Pyridines (pharmacology)
1Pyrimidines (administration & dosage)
1Pyrimidines (pharmacology)
1Serotonin Receptor Agonists (administration & dosage)
1Serotonin Receptor Agonists (pharmacology)
1Serotonin Receptor Agonists (therapeutic use)
1Tachykinins (analysis)
1Tachykinins (metabolism)
1Time Factors
1Tomography, Emission-Computed, Single-Photon (methods)
1Triazoles (administration & dosage)
1Triazoles (pharmacology)
1Tyrosine 3-Monooxygenase (metabolism)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Qin Li" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Qin Li" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Qin Li
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024